Cloning and expression of a cDNA for rat prostaglandin F2 alpha receptor. 1994

J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Osaka University, Japan.

We have cloned a cDNA for rat prostaglandin (PG) F2 alpha receptor from cultured rat astrocytes. The cDNA encodes a polypeptide of 366 amino acids with seven putative transmembrane domains. Specific binding of [3H]PGF2 alpha in membranes of COS-7 cells transfected with the cDNA was displaced with unlabeled PGs in the order of PGF2 alpha > PGD2 > PGE2 > PGI2. In the cDNA-transfected LLC-PK1 cells, PGF2 alpha stimulated phosphoinositide hydrolysis. A significant 4.7-kb mRNA transcript was detected in cultured rat astrocytes and whole brain and pregnant ovary of adult rats by Northern blot analysis.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010716 Phosphatidylinositols Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to the hexahydroxy alcohol, myo-inositol. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid, myo-inositol, and 2 moles of fatty acids. Inositide Phospholipid,Inositol Phosphoglyceride,Inositol Phosphoglycerides,Inositol Phospholipid,Phosphoinositide,Phosphoinositides,PtdIns,Inositide Phospholipids,Inositol Phospholipids,Phosphatidyl Inositol,Phosphatidylinositol,Inositol, Phosphatidyl,Phosphoglyceride, Inositol,Phosphoglycerides, Inositol,Phospholipid, Inositide,Phospholipid, Inositol,Phospholipids, Inositide,Phospholipids, Inositol
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011982 Receptors, Prostaglandin Cell surface receptors that bind prostaglandins with high affinity and trigger intracellular changes which influence the behavior of cells. Prostaglandin receptor subtypes have been tentatively named according to their relative affinities for the endogenous prostaglandins. They include those which prefer prostaglandin D2 (DP receptors), prostaglandin E2 (EP1, EP2, and EP3 receptors), prostaglandin F2-alpha (FP receptors), and prostacyclin (IP receptors). Prostaglandin Receptors,Prostaglandin Receptor,Receptor, Prostaglandin,Receptors, Prostaglandins,Prostaglandins Receptors
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
February 1994, The Journal of biological chemistry,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
January 1995, Advances in prostaglandin, thromboxane, and leukotriene research,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
December 1994, FEBS letters,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
January 1994, The Journal of biological chemistry,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
October 1996, Prostaglandins, leukotrienes, and essential fatty acids,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
August 1995, Endocrinology,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
October 1995, Journal of lipid mediators and cell signalling,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
December 1994, Biochimica et biophysica acta,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
April 1993, The Journal of biological chemistry,
J Kitanaka, and H Hasimoto, and Y Sugimoto, and M Negishi, and H Aino, and M Gotoh, and A Ichikawa, and A Baba
April 1992, The Journal of biological chemistry,
Copied contents to your clipboard!